86 related articles for article (PubMed ID: 2512224)
1. [T-cell depletion today: pros and cons].
Martelli MF; Aversa F
Haematologica; 1989 Oct; 74(5 Suppl):405-17. PubMed ID: 2512224
[No Abstract] [Full Text] [Related]
2. Graft versus host disease prophylaxis today.
Martelli MF; Aversa F
Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
[No Abstract] [Full Text] [Related]
3. T-cell depletion and allogeneic bone marrow transplantation.
O'Reilly RJ
Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
[No Abstract] [Full Text] [Related]
4. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
de Witte T; Preijers F; Schattenberg A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
[No Abstract] [Full Text] [Related]
5. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
[No Abstract] [Full Text] [Related]
6. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
Butturini A; Gale RP
Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
[TBL] [Abstract][Full Text] [Related]
7. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
8. New strategies for T cell depletion.
Butturini A; Gale RP
Bone Marrow Transplant; 1990 Oct; 6(4):225-7. PubMed ID: 2085695
[No Abstract] [Full Text] [Related]
9. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
10. T-cell depletion in unrelated bone marrow transplantation.
Tricot G
Semin Hematol; 1992 Apr; 29(2 Suppl 1):26-31; discussion 31-2. PubMed ID: 1615342
[No Abstract] [Full Text] [Related]
11. T cell depletion in allogenic bone marrow transplantation. Progress and problems.
Marmont AM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():229-32. PubMed ID: 2653509
[No Abstract] [Full Text] [Related]
12. Graft versus host disease.
Gordon-Smith EC
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):413-9. PubMed ID: 2480283
[No Abstract] [Full Text] [Related]
13. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
[No Abstract] [Full Text] [Related]
14. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
15. [Application of monoclonal antibodies to bone marrow transplantation].
Morishima Y
Gan To Kagaku Ryoho; 1988 May; 15(5):1693-701. PubMed ID: 3285796
[TBL] [Abstract][Full Text] [Related]
16. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
Champlin R
Transplant Proc; 1987 Feb; 19(1 Pt 1):157-9. PubMed ID: 3274769
[No Abstract] [Full Text] [Related]
18. T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead.
Prentice HG; Brenner MK; Gottlieb D
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():225-8. PubMed ID: 2653508
[No Abstract] [Full Text] [Related]
19. [Graft-versus-host disease].
Svedentsov EP; Sharygin SL; Epifanov NS; Matveev GA
Klin Med (Mosk); 1993; 71(5):19-23. PubMed ID: 8301977
[No Abstract] [Full Text] [Related]
20. Results of four different protocols for prophylaxis against graft-versus-host disease.
Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
